Bruce A. Samuels, MD

Clinical and Economic Advantages of the iFR Modality for Physiologic Assessment

12/05/2014

Approved by the FDA in March 2014, iFR is a diagnostic tool used to assess whether a stenosis is causing a limitation of blood flow in coronary arteries with subsequent ischemia. This tool preserves the advantages of physiology-based...

Approved by the FDA in March...

12/05/2014

Cath Lab Digest

Rapid Communication

Initial Human Experience with the XIENCE Side-Branch Access Device

05/30/2012

Bruce A. Samuels , MD;

David G. Rizik , MD, FACC, FSCAI;

Thomas R. Hatten , RN, RCIS;

Robert J. Gil , MD, PhD;

Abstract: The everolimus-eluting XIENCE side-branch access (SBA) stent has been the focus of numerous recent publications. Most of the information available on this device comes from the preclinical studies performed in ovine models as well...

Abstract: The everolimus-eluting...

05/30/2012

Journal of Invasive Cardiology